Immediate Download after purchase
Information
- Faculty:
- Alan S. Bloom
- Duration:
- 6 Hours 7 Minutes
- Format:
- Audio and Video
- Copyright:
- Feb 06, 2019
Description
Most clients with DSM-5® diagnoses are being treated with a combination of psychological and pharmacological treatments. Newer drugs are being developed to treat mental disorders based on a better understanding of neurobiological contributions to mental disorders and the latest pharmacological research. To provide appropriate services, you are expected to have a thorough understanding of these common and complex issues. As a mental health professional, keeping up-to-date is essential.
This recording will update and increase your knowledge of:
- Neurobiological underpinnings of major DSM-5® diagnoses
- Effects and side effects of drugs used to treat these diagnoses
- Responsibilities of the non-prescribing therapist to clients taking psychiatric medication
Specifics of the pharmacological treatment and drugs of choice for Depressive, Bipolar, Schizophrenia Spectrum, Anxiety, OCD, Sleep-Wake, ADHD and Neurocognitive disorders will be presented. Unique to this recording is information on the common types of psychotherapeutic drugs and other drugs that are abused, and methods for prevention and early detection. Throughout the day, representative case studies will generate discussion and examination of the latest drug treatment for DSM-5® disorders.
You will leave this recording with knowledge and confidence regarding effective and safe application of pharmacological drugs.
Outline
PSYCHOPHARMACOLOGICAL FOUNDATIONSCore Pharmacological Principles- Brain structures & circuits involved in:
- Emotional regulation
- Executive function & inhibitory control
- Reward & pleasure
- Learning & memory
- Receptors and neurotransmitters important in the actions of psychopharmacological agents
- Biogenic amines
- Excitatory & inhibitory neurotransmitters
- Endorphins & endocannabinoids
Your Role in Combined Psychological & Pharmacological Treatments- Collaboration & communication with prescribing professionals
- Managing the combined treatments
- Referrals for medication
- Client psycho-education
- Monitoring drug effects & side effects
- Promoting adherence to combined treatments
DRUGS USED IN THE TREATMENT OF DSM-5® MENTAL DISORDERSDepressive Disorders
- Neurobiology of depression
- Drugs used to treat depressive disorders
- Selective Serotonin Reuptake inhibitors (SSRIs)
- Effects, side effects and cautions
- Suicide risk & discontinuation syndrome
- Serotonin syndrome
- Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
- Effects, side effects, and cautions
- Atypical antidepressant agents
- Effects, side effects, and cautions
- Tricyclic antidepressants (TCAs)
- Effects, side effects, and cautions
- Why were newer drugs needed?
- MAO inhibitors
- Effects, side effects, and cautions
- Choosing an antidepressant
- What if first-line antidepressants do not work?
- Augmentation with antipsychotics
- What about herbs like St. John’s Wort?
Schizophrenia Spectrum Disorders
- Biological theories of schizophrenia
- ”Typical” & “atypical” antipsychotic drugs
- Effects, side effects & cautions – similarities & differences
- Latest evidence-based comparisons
- Drugs for treatment-resistant schizophrenia
- Other uses of antipsychotic drugs
Bipolar Disorders
- Biological theories for bipolar disorders
- Drugs used to treat bipolar disorders
- A prototype agent-lithium
- Effects, side effects & cautions
- Anticonvulsants
- Effects, side effects & cautions
- Antipsychotics – approved agents
- Combination drug therapy
Anxiety, Obsessive-Compulsive & Sleep-Wake Disorders
- The neurobiology of anxiety-related disorders
- The structure of sleep
- Drugs used in the treatment of anxiety & insomnia
- Benzodiazepines & Benzodiazepine-like drugs
- Misuse of these drugs in treatment
- SSRI’s & other drugs used to treat anxiety
Attention-Deficit/Hyperactivity Disorder & Neurocognitive Disorders (Dementia)
- ADHD
- Psycho-stimulants
- Effects, side effects & cautions
- Alpha-Adrenergic Agonists
- Major neurocognitive disorders
- Drugs used in the treatment of cognitive impairment
- Future treatments
Prescription Drug Abuse
- Mental disorders & risk of comorbid prescription drug abuse
- Classes of drugs that are frequently abused
- Stimulants
- Sedative-hypnotics
- Opiates
- Strategies for the prevention & early identification of prescription drug abuse
LIMITATIONS OF RESEARCH AND POTENTIAL RISKS Faculty
Alan Bloom, Ph.D., is a professor of pharmacology and toxicology at the Medical College of Wisconsin. He earned a joint Ph.D. in psychology and pharmacology and consults regularly with psychiatrists and attorneys in drug abuse and other pharmacology related cases. Dr. Bloom has conducted extensive research on the impact of drugs of abuse (marijuana, cocaine, etc.) on the brain through use of functional magnetic resonance imaging (fMRI). His studies have been funded by the NIH and other national organizations and reported in an extensive number of publications and presentations. Dr. Bloom has served on the NIDA center grant review panel and is an appointed member of the Controlled Substance Board of the State of Wisconsin. He is a strong and experienced presenter providing lively, information-packed seminars.
Speaker Disclosures:
Speaker Disclosures: Speaker Disclosure: Financial: Alan Bloom is a Professor of Pharmacology and Toxicology at the Medical College of Wisconsin. He receives a speaking honorarium from PESI, Inc.
Non-financial: Alan Bloom is the vice-chair for the State of Wisconsin Controlled Substances Board.
